Vorob'eva A.A.,Russian Academy of Medical Sciences |
Ivanova M.V.,Russian Academy of Medical Sciences |
Fominykh V.V.,Russian Academy of Medical Sciences |
Zakharova M.N.,Russian Academy of Medical Sciences |
And 2 more authors.
Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova | Year: 2013
Identification of biomarkers in multiple sclerosis is a very complex problem, and intensive work is being made in this field for the last decades. The importance of establishing biomarkers of multiple sclerosis is related to the high disease heterogeneity and lack of characteristic symptoms that leads to diagnostic, prognostic challenges and difficulties in making decisions about therapy. In this paper, we review the most important biomarkers and discuss their diagnostic and prognostic value. Experimental results on neurofilament heavy chains and antibodies to sulfatide in multiple sclerosis are presented.